Found: 9
Select item for more details and to access through your institution.
Stunt or elongate? Two opposite strategies by which rice adapts to floods.
- Published in:
- Journal of Plant Research, 2010, v. 123, n. 3, p. 303, doi. 10.1007/s10265-010-0332-7
- By:
- Publication type:
- Article
Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy.
- Published in:
- Ophthalmologica, 2021, v. 244, n. 4, p. 347, doi. 10.1159/000517187
- By:
- Publication type:
- Article
Metabolite and Phytohormone Profiling Illustrates Metabolic Reprogramming as an Escape Strategy of Deepwater Rice during Partially Submerged Stress.
- Published in:
- Metabolites (2218-1989), 2020, v. 10, n. 2, p. 68, doi. 10.3390/metabo10020068
- By:
- Publication type:
- Article
The ethylene response factors SNORKEL1 and SNORKEL2 allow rice to adapt to deep water.
- Published in:
- Nature, 2009, v. 460, n. 7258, p. 1026, doi. 10.1038/nature08258
- By:
- Publication type:
- Article
Vacuolar Proton Pumps and Aquaporins Involved in Rapid Internode Elongation of Deepwater Rice.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2011, v. 75, n. 1, p. 114, doi. 10.1271/bbb.100615
- By:
- Publication type:
- Article
Improvements of retinal sensitivity, visual acuity, and central retinal thickness after intravitreal injection of aflibercept in patients with wet age‐related macular degeneration.
- Published in:
- Acta Ophthalmologica (1755375X), 2019, v. 97, p. N.PAG, doi. 10.1111/j.1755-3768.2019.5247
- By:
- Publication type:
- Article
In reply.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 2, p. 205, doi. 10.1002/pds.1914
- By:
- Publication type:
- Article
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 2, p. 196, doi. 10.1002/pds.1870
- By:
- Publication type:
- Article
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10565, doi. 10.3390/ijms241310565
- By:
- Publication type:
- Article